lisdexamfetamine dimesylate

Drug ingredientActive Shortage

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

Where It Comes From

32 FDA-registered drug labelers

Alvogen Inc.

American Health Packaging

American Pacific Corporation

Amneal Pharmaceuticals LLC

Apotex Corp.

AvKARE

Azurity Pharmaceuticals, Inc.

Bryant Ranch Prepack

Camber Pharmaceuticals, Inc.

Cambrex Charles City, Inc

Chattem Chemicals, Inc.

Curia New York, Inc.

Elite Laboratories, Inc.

Euticals, Inc.

Granules India Limited

Granules Pharmaceuticals Inc.

Hikma Pharmaceuticals USA Inc.

Lannett Company, Inc.

Mylan Pharmaceuticals Inc.

Noramco, LLC

Novadoz Pharmaceuticals LLC

Patheon Manufacturing Services LLC

Patheon Pharmaceuticals Inc.

Rhodes Pharmaceuticals

S&B Pharma LLC dba Norac Pharma

Sandoz Inc

Solco Healthcare US,LLC

SpecGx LLC

Sun Pharmaceutical Industries, Inc.

Takeda Pharmaceuticals America, Inc.

Teva Pharmaceuticals, Inc.

Veranova, L.P.

Why It Matters

Sectors

Health

Downstream Uses

Appears in 3 drug and cosmetic product listings (FDA).

•Lisdexamfetamine Dimesylate
•Arynta
•Vyvanse

FDA Shortage Status

Active Shortage

Shortage History

current

Lisdexamfetamine Dimesylate Capsule

11/01/2023

Available

current

Lisdexamfetamine Dimesylate Capsule

07/14/2023

Limited Availability

current

Lisdexamfetamine Dimesylate Tablet, Chewable

07/14/2023

Available

current

Lisdexamfetamine Dimesylate Capsule

07/14/2023

Available

current

Lisdexamfetamine Dimesylate Capsule

01/11/2024

Available

current

Lisdexamfetamine Dimesylate Capsule

09/20/2023

Available

current

Lisdexamfetamine Dimesylate Capsule

07/14/2023

Unavailable

Chemical Identity

CAS608137-33-3

PubChem CID11597697

DTXSIDDTXSID60209653

FormulaC17H33N3O7S2

Mol. Weight455.6 g/mol

SMILESCC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O

Data Sources

115976972026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/lisdexamfetamine dimesylate/cids/JSON

Archive: data/sources/pubchem_name/lisdexamfetamine dimesylate.json

CAS 608137-33-32026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

CAS 608137-33-32026-06-13

https://api.fda.gov/drug/shortages.json

Archive: data/sources/fda/shortages/shortages.json

← Back to Dashboard ← Back to Health